1. A pharmaceutical composition comprising octreotide acetate microparticles made from a linear copolymer of lactide with glycolide, in which the polymer contains less than 1% silicone oil or heptane, preferably without silicone oil or heptane. ! 2. A pharmaceutical composition comprising octreotide acetate microparticles made from a linear copolymer of lactide with glycolide, in a mixture or in association with a diluent comprising a nonionic surfactant. ! 3. The pharmaceutical composition according to claim 1 or 2, further comprising a substance that prevents agglomeration. ! 4. A method of producing microparticles of octreotide acetate, comprising the steps of:! a) dissolving or dispersing octreotide acetate in methylene chloride containing a dissolved linear copolymer of lactide with glycolide, to obtain a dispersion； ! b) combining said dispersion with an effective amount of a continuous working medium to obtain an emulsion that contains said continuous working medium and microdroplets comprising said octreotide acetate, said solvent and said linear copolymer of lactide with glycolide； and! C) immediately after the formation of the specified emulsion of a single addition of the specified emulsion to an effective amount of an extracting medium for extracting the specified solvent from these microdroplets with obtaining these microparticles. ! 5. A method of producing octreotide acetate microparticles by the method of repeated emulsification, the improvement of which includes the stages:! a) dissolving octreotide acetate in water, emulsifying an aqueous solution of octreotide acetate in methylene chloride,1. Фармацевтическая композиция, включающая микрочастицы октреотидацетата, изготовленные из линейного сополимера лактида с гликолидом, в которой полимер содержит менее 1% силиконового масла или гептана, предпочтительно, не содержащего силиконового масла или гептана. ! 2. Фармацевтическая композиция, включающая микрочастицы октреотидацетата, изготовленные из лине
